INTERACTION OF BOVINE SERUM-ALBUMIN WITH THE SURFACE OF A MICROCRYSTALLINE ALUMINUM-OXIDE HYDROXIDE COMPOUND - A POSSIBLE NEW TYPE OF PHOSPHATE ADSORBENT

被引:7
作者
NISHIDA, M
OOKUBO, A
HASHIMURA, Y
IKAWA, A
YOSHIMURA, Y
OOI, K
SUZUKI, T
TOMITA, Y
KAWADA, J
机构
[1] TOMITA PHARMACEUT CO LTD,NARUTO 77103,JAPAN
[2] GOVT IND RES INST,TAKAMATSU 761,JAPAN
关键词
D O I
10.1002/jps.2600810822
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Aluminum hydroxide gel (ALG) has been effective for ameliorating acidosis associated with phosphatemia caused by hemodialysis. However, aluminum accumulation in the body causes severe side effects. As substitute for ALG, a new type of aluminum oxide hydroxide (tentatively named PT-A) was prepared with the hope of future clinical use. PT-A has a microcrystalline structure with a high resistance to pH change and has more phosphate-binding efficacy than ALG. It was tested for possible interaction with protein by adsorption test, zeta-potential analysis, X-ray diffraction, and scanning electron microscopy. Bovine serum albumin (BSA) was chosen as a model protein. The interaction of BSA with PT-A depended on the amount of adsorbent. Protein adsorption occurred rapidly and reached the maximal level at near neutral pHs. Phosphate adsorption was not affected by the presence of BSA, but the interaction of BSA with PT-A was significantly reduced by the presence of phosphate. Zeta-potential changes on the surface of PT-A indicated that the positively charged surface of PT-A was covered with negatively charged phosphate ions that repelled negatively charged BSA molecules. X-ray diffraction patterns indicated no observable structural alteration caused by adsorption of BSA or phosphate, and scanning electron microscopy revealed that BSA covered the outer surface of PT-A but did not cover small pores, where phosphate can freely penetrate.
引用
收藏
页码:828 / 831
页数:4
相关论文
共 17 条
[1]   DIALYSIS ENCEPHALOPATHY SYNDROME - POSSIBLE ALUMINUM INTOXICATION [J].
ALFREY, AC ;
LEGENDRE, GR ;
KAEHNY, WD .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (04) :184-188
[2]  
ALFREY AC, 1986, KIDNEY INT S18, V29, pS53
[3]   SUBSTITUTION OF CALCIUM-CARBONATE FOR ALUMINUM HYDROXIDE IN PATIENTS ON HEMODIALYSIS - EFFECTS ON ACIDOSIS, ON PARATHYROID FUNCTION, AND ON CALCEMIA [J].
ANELLI, A ;
BRANCACCIO, D ;
DAMASSO, R ;
PADOVESE, P ;
GALLIENI, M ;
GARELLA, S .
NEPHRON, 1989, 52 (02) :125-132
[4]   CHEMICAL-REACTIVITY OF ALUMINUM-BASED PHARMACEUTICAL COMPOUNDS USED AS PHOSPHATE-BINDERS [J].
CARGILL, RW ;
DUTKOWSKIJ, M ;
PRESCOTT, A ;
FLEMING, LW ;
STEWART, WK .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (01) :11-16
[5]  
Cournot-Witmer G, 1984, Contrib Nephrol, V38, P59
[6]   RENAL OSTEODYSTROPHY - PATHOGENESIS AND TREATMENT [J].
CUSHNER, HM ;
ADAMS, ND .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1986, 291 (04) :264-275
[7]  
GALLIENI M, 1989, NEPHRON, V52, P125
[8]   THE USE OF MAGNESIUM-CONTAINING PHOSPHATE BINDERS IN PATIENTS WITH END-STAGE RENAL-DISEASE ON MAINTENANCE HEMODIALYSIS [J].
GUILLOT, AP ;
HOOD, VL ;
RUNGE, CF ;
GENNARI, FJ .
NEPHRON, 1982, 30 (02) :114-117
[9]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[10]   THE RISKS AND BENEFITS OF A LOW PROTEIN ESSENTIAL AMINO-ACID KETO ACID DIET [J].
LUCAS, PA ;
MEADOWS, JH ;
ROBERTS, DE ;
COLES, GA .
KIDNEY INTERNATIONAL, 1986, 29 (05) :995-1003